Table 3.

 Multiple logistic regression analysis examining association between hepatocellular carcinoma (HCC) and diabetes, adjusting for age, sex, race, SEER registry, and Medicare/Medicaid dual enrolment (n = 8244)

	OR	95% CI	Wald χ2 test	p Value
Diabetes
No	1.00	–	–	Reference
Yes	3.08	2.74–3.46	469.04	<0.0001
Age at HCC diagnosis
<75 y	1.00	–	–	Reference
⩾75 y	0.69	0.62–0.77	40.68	<0.0001
Sex
Female	1.00	–	–	Reference
Male	3.70	3.23–4.17	500.99	<0.0001
Race
White	1.00	–	–	Reference
Black	1.27	1.03–1.57	4.88	0.0272
Hispanic	1.22	0.90–1.65	1.57	0.2096
Asian	2.37	1.89–2.98	55.17	<0.0001
Other	2.14	1.67–2.73	36.72	<0.0001
Registry
Atlanta	1.00	–	–	Reference
Utah	0.62	0.42–0.92	5.55	0.0185
Connecticut	0.89	0.66–1.20	0.59	0.4419
Detroit	1.07	0.81–1.43	0.25	0.6204
Hawaii	0.67	0.45–0.99	4.03	0.0446
Iowa	0.86	0.63–1.16	0.9928	0.3191
Los Angeles	0.68	0.51–0.88	7.86	0.0050
New Mexico	0.97	0.69–1.38	0.0230	0.8794
San Francisco	0.71	0.53–0.96	4.88	0.0272
San Jose	0.65	0.45–0.93	5.49	0.0191
Seattle	0.89	0.66–1.21	0.5351	0.4645
Medicare/Medicaid dual enrolment	2.19	1.87–2.56	96.36	<0.0001

OR, odds ratio; 95% CI, 95% confidence interval.